EUVIMEDEUVIMED entdecken
Multizentrische Studie

Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis

Gundolf Schuettfort iD, Jan Borch, Alfonso Cabello iD, Maria Crusells, Miguel Górgolas, Eva Herrmann, Carmen Hidalgo-Tenorio iD, Juan Lopez, Rafael Mican iD, Roser Navarro-Soler, Eugenia Negredo, Sebastian Noe und 10 weitere

HIV Medicine · 2026-01 · 27 (1) · 96-105

DOI: 10.1111/hiv.70119 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift HIV Medicine, online erschienen am 07.10.2025. Verfasst von Gundolf Schuettfort und 21 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Frankfurt, Frankfurt, Germany. Hauptthemen laut MEDLINE: HIV Infections, Lamivudine, Anti-HIV Agents, Anti-Retroviral Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the efficacy and safety of first‐line antiretroviral treatment (ART) with 2DR dolutegravir/lamivudine (DTG/3TC) versus 3DR bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC) in persons with low CD4 cell counts and/or an AIDS‐defining disease.

Design

Retrospective, multicentre, multinational study.

Methods

We conducted a retrospective, multicentre, multinational analysis to investigate the virological response and discontinuation rate in people living with HIV starting first‐line ART with a CD4 cell count

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsLamivudineAnti-HIV AgentsAnti-Retroviral AgentsHumansMaleFemaleRetrospective StudiesAdultMiddle AgedCD4 Lymphocyte CountPyridonesViral LoadEmtricitabinePiperazinesHeterocyclic Compounds, 3-RingOxazinesTenofovirTreatment OutcomeAntiretroviral Therapy, Highly ActiveHIV-1AmidesDolutegravir

Stichwörter der Autor:innen

2DR3DRAIDSHIVbictegravirdolutegravirlate diagnosis

Substanzen

LamivudinePyridonesAnti-HIV AgentsEmtricitabinePiperazinesHeterocyclic Compounds, 3-RingOxazinesTenofovirAnti-Retroviral AgentsAmides

Autor:innen und Institutionen

  • University Hospital Frankfurt, Frankfurt, Germany.
  • Praxis Goldstein, Berlin, Germany.
  • Hospital Universitario Fundacion Jimenez Diaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, (IIS-FJD, UAM), Madrid, Spain.
  • Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Hospital Universitario Gregorio Maranon, Madrid, Spain.

ORCID-Profile: Gundolf Schuettfort, Alfonso Cabello, Carmen Hidalgo-Tenorio, Rafael Mican, Juergen Rockstroh, Christoph Stephan

Zitieren

APA

Schuettfort, G., Borch, J., Cabello, A., Crusells, M., Górgolas, M., Herrmann, E., Hidalgo-Tenorio, C., Lopez, J., Mican, R., Navarro-Soler, R., Negredo, E., Noe, S., Puig, J., Pulido, F., Serrao, R., Rockstroh, J., Rodriguez, S., Stephan, C., Torralba, M., …, & Haberl, A. E. (2026). Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis. HIV Medicine, 27(1), 96-105. https://doi.org/10.1111/hiv.70119

Vancouver

Schuettfort G, Borch J, Cabello A, Crusells M, Górgolas M, Herrmann E, et al. Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis. HIV Medicine. 2026;27(1):96-105. doi:10.1111/hiv.70119

BibTeX
@article{Schuettfort2026,
  author = {Schuettfort, Gundolf and Borch, Jan and Cabello, Alfonso and Crusells, Maria and Górgolas, Miguel and Herrmann, Eva and Hidalgo-Tenorio, Carmen and Lopez, Juan and Mican, Rafael and Navarro-Soler, Roser and Negredo, Eugenia and Noe, Sebastian and Puig, Jordi and Pulido, Federico and Serrao, Rosario and Rockstroh, Juergen and Rodriguez, Sergio and Stephan, Christoph and Torralba, Miguel and Trigo, Diva and Vehreschild, Maria and Haberl, Annette E},
  title = {Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis},
  journal = {HIV Medicine},
  year = {2026},
  volume = {27},
  number = {1},
  pages = {96--105},
  doi = {10.1111/hiv.70119}
}
Kostenlos starten →